Croma-Pharma GmbH se félicite de l’approbation d’Obagi saypha® MagIQ™ par la FDA aux États-Unis
LONDRES, 10 septembre 2025 /PRNewswire/ — Croma-Pharma GmbH, leader mondial de la médecine esthétique mini-invasive, est fier d’annoncer que la Food and Drug Administration (FDA) des États-Unis a approuvé le gel injectable d’acide hyaluronique (AH) Obagi saypha® MagIQ™, le premier produit de comblement intradermique de la collection Obagi saypha®, pour une utilisation commerciale sur le […]
West Fraser Declares Dividend
VANCOUVER, BC, Sept. 10, 2025 /PRNewswire/ – West Fraser Timber Co. Ltd. (“West Fraser” or the “Company”) (TSX andNYSE: WFG) has declared a quarterly dividend of US$0.32 per share on the Common shares and Class B Common shares in the capital of the Company, payable on October 14, 2025 to shareholders of record on September 25, 2025. Dividends […]
Alaska Air Group Announces Leadership Transition at Hawaiian Airlines and Executive Promotion at Alaska Airlines
• Diana Birkett Rakow to be named CEO of Hawaiian Airlines, succeeding Joe Sprague who will retire this Fall after a distinguished career in aviation. • Kyle Levine to be promoted to Executive Vice President, Corporate & Public Affairs, Chief Legal Officer and Corporate Secretary and assume responsibility for Public and Government Affairs. SEATTLE and […]
Alithya announces directors’ election results
MONTREAL, Sept. 10, 2025 /PRNewswire/ – Alithya Group inc. (TSX: ALYA) (“Alithya” or the “Company”) today held its annual general meeting of shareholders (the “Meeting”) virtually. A total of 40,521,385 Class A subordinate voting shares and 7,326,880 Class B multiple voting shares were represented at the Meeting, representing approximately 68.58% of the total votes attached to […]
Oxford-Harrington Rare Disease Centre Announces David Cameron, Chair of its Advisory Council, as a Guest Speaker at Morgan Stanley Exchange 2025
In ‘A Conversation on Courage,’ Lord Cameron and Morgan Stanley’s Andy Saperstein discussed philanthropy as a catalyst for rare disease innovation OXFORD, England and CLEVELAND, Sept. 10, 2025 /PRNewswire/ — The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, dedicated to […]
Silverts Expands Portfolio with Acquisition of IZ Adaptive
TORONTO, Sept. 10, 2025 /PRNewswire/ – Silverts, North America’s leading adaptive apparel brand with nearly 100 years of expertise in accessible fashion, announces the acquisition of IZ Adaptive, the award-winning adaptive clothing line founded by Canadian designer Izzy Camilleri. This strategic move unites two pioneers in adaptive fashion to accelerate innovation, expand distribution, and provide stylish, functional […]
Hilco Real Estate Sales Announces Bankruptcy Sale of Victoria Tower Office Building in Victoria, Texas
NORTHBROOK, Ill., Sept. 10, 2025 /PRNewswire/ — Hilco Real Estate Sales announces October 30, 2025, as the qualifying bid deadline for the Chapter 11 bankruptcy sale of Victoria Tower, a prominent six-story office property strategically located at 1908 N Laurent Street in Victoria, Texas. Victoria Tower contains 111,856± square feet of gross building area with 104,694± rentable […]
$340M refinancing secured for 50 & 70 Columbus in Jersey City
JLL and BlueGate Partners LLC arranges refinancing for premier mixed-use property in Jersey City’s Waterfront district MORRISTOWN, N.J., Sept. 10, 2025 /PRNewswire/ – JLL‘s Capital Markets group, in conjunction with BlueGate Partners LLC, announced today that it has arranged a $340 million refinancing for 50 & 70 Columbus, a 938-unit mixed-use property located in Jersey City, […]
Strider Technologies:colaboración con el programa de aceleración de la innovación en defensa de la OTAN
-Strider Technologies anuncia una colaboración con el programa de aceleración de la innovación en defensa de la OTAN La iniciativa DIANA de la OTAN aprovechará la inteligencia estratégica de Strider como herramienta de seguridad económica. LONDRES, 10 de septiembre de 2025 /PRNewswire/ — Strider Technologies, Inc., líder en el sector de la inteligencia estratégica, ha […]
Tagworks Pharmaceuticals inicia la tercera dosis del ensayo clínico de fase 1 de TGW101
– Tagworks Pharmaceuticals anuncia el inicio de la tercera dosis del ensayo clínico de fase 1 de TGW101 para el tratamiento de tumores sólidos TGW101 es un ADC de última generación, el primero en su clase, dirigido a TAG-72 con una carga útil MMAE, desarrollado con base en la química de enlace Click-to-Release, propiedad de Tagworks. […]